Red Blood Cell Distribution Width As A Prognostic Biomarker for Viral Infections: Prospects and Challenges
Oloche Owoicho, Kesego Tapela, Charles Ochieng’ Olwal, Alexandra Lindsey Djomkam Zune, Nora Nghochuzie Nganyewo, Osbourne Quaye
Abstract
Viral diseases remain a significant global health threat, and therefore prioritization of limited healthcare resources is required to effectively manage dangerous viral disease outbreaks. In a pandemic of a newly emerged virus that is yet to be well understood, a noninvasive host-derived prognostic biomarker is invaluable for risk prediction. Red blood cell distribution width (RDW), an index of red blood cell size disorder (anisocytosis), is a potential predictive biomarker for severity of many diseases. In view of the need to prioritize resources during response to outbreaks, this review highlights the prospects and challenges of RDW as a prognostic biomarker for viral infections, with a focus on hepatitis and COVID-19, and provides an outlook to improve the prognostic performance of RDW for risk prediction in viral diseases.